MicroRNA molecules interacting with a liver cell.

Decoding Liver Cancer: Can MicroRNAs Be the Key to New Therapies?

Rhea Morgan in Health & Wellness November 2025 • 5 min read.

"Unlocking the potential of microRNA in targeting IQGAP proteins for liver cancer treatment and exploring innovative therapeutic avenues."

Liver cancer, predominantly hepatocellular carcinoma (HCC), stands as a formidable global health challenge, ranking among the leading causes of cancer-related deaths. In Indonesia, its impact is particularly pronounced, with mortality rates significantly higher in males. While conventional treatments like chemotherapy, surgery, and radiation therapy offer some relief, the rise of chemoresistance underscores the urgent need for innovative, targeted approaches.

Enter microRNAs (miRNAs), small non-coding RNA molecules that regulate gene expression by binding to messenger RNAs (mRNAs), either inhibiting their translation or promoting their degradation. Recent studies suggest that miRNAs play a crucial role in various biological processes, including cancer development. These tiny molecules can act as either oncogenes, promoting cancer, or tumor suppressors, hindering its progression, depending on their target genes.

A family of proteins known as IQ motif-containing GTPase-activating proteins (IQGAPs) has emerged as significant players in cancer. These proteins, including IQGAP1, IQGAP2, and IQGAP3, are involved in regulating cellular processes like cell adhesion and migration. Aberrant expression of IQGAPs has been implicated in several cancers, with some studies suggesting they can act as oncogenes, while others indicate tumor-suppressing capabilities. This dual role makes IQGAPs an intriguing target for cancer therapy.

How Can Targeting IQGAP Proteins with MicroRNAs Revolutionize Liver Cancer Treatment?

MicroRNA molecules interacting with a liver cell.

New research employs advanced computational methods to identify specific miRNAs that regulate IQGAP gene expression in liver cancer. By analyzing data from The Cancer Genome Atlas (TCGA), scientists have uncovered correlations between miRNA expression and IQGAP family members. This approach allows researchers to pinpoint miRNAs that could potentially inhibit or activate IQGAP proteins, influencing cancer development.

The study involved a detailed correlation analysis using data from TCGA, focusing on liver cancer samples. The researchers constructed expression matrices for both miRNAs and IQGAP genes, ensuring the data were aligned by patient sample. Spearman rank correlation coefficients were then calculated to determine the strength and direction of the relationship between miRNA and IQGAP expression levels. This statistical method is particularly useful for handling outliers and non-normal data distributions, providing robust results.

Data Collection and Preprocessing: Gene and miRNA expression data were collected from the TCGA database, focusing on liver cancer samples. The data were preprocessed to ensure consistency and accuracy.
Correlation Analysis: Spearman rank correlation coefficients were computed to identify miRNAs that show a significant inverse correlation with IQGAP gene expression.
miRTarBase Validation: The identified miRNA-IQGAP interactions were compared against the miRTarBase database, which contains experimentally validated miRNA-target interactions, to validate the findings.

The findings revealed significant inverse correlations between specific miRNAs and IQGAP genes. For instance, several miRNAs were found to be negatively correlated with IQGAP1, IQGAP2, and IQGAP3 expression, suggesting that these miRNAs could potentially suppress IQGAP activity. Importantly, some of these interactions were also validated by the miRTarBase database, strengthening the credibility of the results. These validated interactions highlight the potential for targeted miRNA therapies to modulate IQGAP expression and thereby influence liver cancer progression.

The Future of Liver Cancer Therapy: Harnessing the Power of MicroRNAs

This research marks a significant step forward in understanding the complex interplay between miRNAs and IQGAP proteins in liver cancer. By identifying specific miRNAs that regulate IQGAP expression, scientists are paving the way for the development of novel, targeted therapies. Future studies will focus on validating these findings through in vitro and in vivo experiments, as well as exploring the potential of miRNA-based therapeutics to improve outcomes for patients with liver cancer. Ultimately, this innovative approach could revolutionize the way we treat this deadly disease, offering new hope for those affected.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.22159/ajpcr.2018.v11s3.30046, Alternate LINK

Title: In Silico Study Of Mirna-Regulated Iq Motif-Containing Gtpase-Activating Protein Family In Liver Cancer

Subject: Pharmacology (medical)

Journal: Asian Journal of Pharmaceutical and Clinical Research

Publisher: Innovare Academic Sciences Pvt Ltd

Authors: David Agustriawan, Anton Sumarpo, Arli Aditya Parikesit, Rizky Nurdiansyah, Gabriella Patricia Adisurja, Ricky Ravindra Fajar Ap

Published: 2018-10-03

Everything You Need To Know

What exactly are microRNAs (miRNAs) and how do they function in the context of liver cancer?

MicroRNAs (miRNAs) are small, non-coding RNA molecules that play a crucial role in regulating gene expression. They achieve this by binding to messenger RNAs (mRNAs), which can either inhibit the translation of these mRNAs or promote their degradation. In the context of liver cancer, miRNAs can act as either oncogenes, which promote cancer development, or as tumor suppressors, which hinder its progression, depending on the specific genes they target. Understanding and manipulating these miRNAs offers potential therapeutic avenues for liver cancer treatment.

What are IQGAP proteins, and why are they considered a significant factor in liver cancer development?

IQGAP proteins, specifically IQGAP1, IQGAP2, and IQGAP3, are involved in regulating critical cellular processes such as cell adhesion and migration. Their expression levels and activity have been shown to be aberrant in various cancers, including liver cancer. While some studies suggest they act as oncogenes, others indicate tumor-suppressing capabilities, making them intriguing yet complex targets for cancer therapy. Targeting IQGAP proteins with microRNAs aims to modulate their activity and influence cancer progression.

What advanced computational methods were used to identify miRNAs that regulate IQGAP gene expression?

Researchers analyzed data from The Cancer Genome Atlas (TCGA) to find correlations between miRNA expression and IQGAP family members in liver cancer samples. They used Spearman rank correlation coefficients to identify miRNAs that show a significant inverse relationship with IQGAP gene expression. This statistical method is particularly useful for handling outliers and non-normal data distributions, providing robust results. The team then validated the miRNA-IQGAP interactions by comparing them against the miRTarBase database, which contains experimentally validated miRNA-target interactions.

What specific correlations were found between microRNAs and IQGAP genes in liver cancer cells?

The research identified specific miRNAs that are negatively correlated with the expression of IQGAP1, IQGAP2, and IQGAP3. This suggests that these miRNAs could potentially suppress the activity of IQGAP proteins. Several of these interactions were validated by the miRTarBase database. These validated interactions indicate that targeted miRNA therapies could be developed to modulate IQGAP expression, which in turn, could influence the progression of liver cancer. However, the full implications of these interactions need further study to translate to therapies.

How might targeting IQGAP proteins with microRNAs offer new therapeutic strategies, and what are the future implications for liver cancer treatment?

Targeting IQGAP proteins with microRNAs offers a pathway for developing new treatments. This approach allows for a more targeted and personalized treatment strategy. Further research is necessary to validate these findings through in vitro and in vivo experiments. These future studies will explore the potential of miRNA-based therapeutics to improve outcomes for patients with liver cancer, with the ultimate goal of revolutionizing the way liver cancer is treated and offering new hope for those affected.